MIMEDX Group, Inc.
$3.4M 12,157 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Integra LifeSciences Corporation
Integra LifeSciences Corporation reported $3,397,378.64 across General Payments, Research, and Ownership to 18,727 physicians and teaching hospitals across 18,806 transactions.
- $3.4M
- All-tracks total
- 18,806
- Transactions
- 18,727
- Recipients
- +$740.4K
- General Payments vs PY2023
Integra LifeSciences Corporation reported $3,397,378.64 across all CMS Open Payments tracks (General + Research + Ownership) to 18,727 physicians and teaching hospitals in Program Year 2024 - ranking #334 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $3,028,316.26, averaging $181.42 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer integra-lifesciences-corporation Integra LifeSciences Corporation
$3.4M · #334/1,925 · 0.0% industry · PY2024
- TOT $3.4M
- RANK #334
- SHARE 0.0%
- TXN 18,806
- RCP 18,727
- CAT 7
- GEN $3.0M
- ΔGEN +$740.4K
- TOP1 3.1%
- PY 2024
Volume peers
Nearest volume peer: MIMEDX Group, Inc. ($3.4M)
Integra LifeSciences Corporation sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Integra LifeSciences Corporation's CMS-reported General Payments increased by $740.4K (+32.4%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: INTEGRA LIFESCIENCES CORPORATIONPY2023: INTEGRA LIFESCIENCES CORPORATIONPY2024: Integra LifeSciences Corporation. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $2,287,958.68
- PY2024
- $3,028,316.26
What the Data Shows for Integra LifeSciences Corporation
Rank #334 of 1,925 companies in CMS Open Payments for 2024 belongs to Integra LifeSciences Corporation, which reported $3,397,378.64 across 18,806 transactions to 18,727 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $180.65 per transaction and $181.42 per recipient.
413 transactions worth $1.1M make "Consulting Fee" the top general-payment category in the 7-category breakdown below, 36.8% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Integra LifeSciences Corporation made 7 types of general payments. "Consulting Fee" is the largest category at $1.1M, 36.8% of General Payments.
Integra LifeSciences Corporation reports 7 general-payment categories - the top three are Consulting Fee (36.8%), Food and Beverage (29.2%), and Travel and Lodging (16.0%). The remaining 4 categories make up 18.0% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Integra LifeSciences Corporation divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $1.1M | 413 | 36.8% |
| Food and Beverage | $883.9K | 16,146 | 29.2% |
| Travel and Lodging | $483.2K | 1,067 | 16.0% |
| Long-Term Medical Supply or Device Loan | $363.3K | 1,087 | 12.0% |
| Grant | $163.0K | 7 | 5.4% |
| Royalty or License | $19.3K | 4 | 0.6% |
| Education | $488.18 | 3 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $339,762.06 (11.2%) of $3,028,316.26 in this company's General Payments records across 10,292 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Integra LifeSciences Corporation
The five named recipients with the highest reported General Payments from this company
- 1
Ian L Valerio
$92,759.48 across 54 reported transactions
- 2
John Fischer
$67,826.33 across 44 reported transactions
- 3
Paul Deramo
$62,264.64 across 81 reported transactions
- 4
Lehigh Valley
$60,000.00 across 1 reported transactions
- 5
Harrison M Cotler
$56,911.61 across 64 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Integra LifeSciences Corporation's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Integra LifeSciences Corporation.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Integra LifeSciences Corporation.
Showing 6 of 1,924 companies with CMS-reported payment data.
Elekta, Inc.
$3.4M 610 recipients
Compare payment profiles
Puma Biotechnology, Inc.
$3.5M 5,232 recipients
Compare payment profiles
Oyster Point Pharma, Inc.
$3.3M 19,684 recipients
Compare payment profiles
Merit Medical Systems Inc
$3.3M 1,352 recipients
Compare payment profiles
Biotissue Holdings Inc.
$3.3M 20,909 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.